Literature DB >> 10456888

Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.

G Nussbaum1, S Anandasabapathy, J Mukherjee, M Fan, A Casadevall, M D Scharff.   

Abstract

The antibody response to Cryptococcus neoformans capsular glucuronoxylomannan (GXM) in BALB/c mice frequently expresses the 2H1 idiotype (Id) and is restricted in variable gene usage. This study examined the immunogenicity of GXM-protein conjugates, V (variable)-region usage, and 2H1 Id expression in seven mouse strains: BALB/c, C57BL/6, A/J, C3H, NZB, NZW, and (NZB x NZW)F(1) (NZB/W). All mouse strains responded to vaccination with GXM conjugated to tetanus toxoid (TT), the relative magnitude of the antibody response being BALB/c approximately C3H > C57BL/6 approximately NZB approximately NZW approximately NZB/W > A/J. Analysis of serum antibody responses to GXM with polyclonal and monoclonal antibodies to the 2H1 Id revealed significant inter- and intrastrain differences in idiotype expression. Thirteen monoclonal antibodies (MAbs) (two immunoglobulin M [IgM], three IgG3, one IgG1, three IgG2a, two IgG2b, and two IgA) to GXM were generated from one NZB/W mouse and one C3H/He mouse. The MAbs from the NZB/W mouse were all 2H1 Id positive (Id(+)) and structurally similar to those previously generated in BALB/c mice, including the usage of a V(H) from the 7183 family and Vkappa5.1. Administration of both 2H1 Id(+) and Id(-) MAbs from NZB/W and C3H/H3 mice prolonged survival in a mouse model of cryptococcosis. Our results demonstrate (i) that V-region restriction as indicated by the 2H1 Id is a feature of both primary and secondary responses of several mouse strains; and (ii) that there is conservation of V-region usage and length of the third complementarity-determining region in antibodies from three mouse strains. The results suggest that V-region restriction is a result of antibody structural requirements necessary for binding an immunodominant antigen in GXM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456888      PMCID: PMC96766     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.

Authors:  F Dromer; P Yeni; J Charreire
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

2.  Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.

Authors:  J Geliebter; R A Zeff; R W Melvold; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 3.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

Review 4.  Development of vaccines and their use in the prevention of fungal infections.

Authors:  D M Dixon; A Casadevall; B Klein; L Mendoza; L Travassos; G S Deepe
Journal:  Med Mycol       Date:  1998       Impact factor: 4.076

5.  Molecular basis of a mouse strain-specific anti-hapten response.

Authors:  D Y Loh; A L Bothwell; M E White-Scharf; T Imanishi-Kari; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

6.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.

Authors:  A J Feeney; S H Clarke; D E Mosier
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

8.  Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness.

Authors:  T R Kozel; W F Gulley; J Cazin
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Regulation of the anti-inulin antibody response by a nonallotype-linked gene.

Authors:  K E Stein; C Bona; R Lieberman; C C Chien; W E Paul
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  7 in total

1.  Limiting CDR-H3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 dextran.

Authors:  Tamer I Mahmoud; Harry W Schroeder; John F Kearney
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

2.  Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.

Authors:  A Nakouzi; P Valadon; J Nosanchuk; N Green; A Casadevall
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.

Authors:  Cheryl D Chun; Jessica C S Brown; Hiten D Madhani
Journal:  Cell Host Microbe       Date:  2011-03-17       Impact factor: 21.023

Review 4.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

5.  The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.

Authors:  Antonio Nakouzi; Tong Zhang; Stefan Oscarson; Arturo Casadevall
Journal:  Vaccine       Date:  2009-04-19       Impact factor: 3.641

6.  Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB.

Authors:  Mariem Ben-Abdallah; Aude Sturny-Leclère; Patrick Avé; Anne Louise; Frédérique Moyrand; Falk Weih; Guilhem Janbon; Sylvie Mémet
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

7.  Cryptococcus neoformans Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model.

Authors:  Ana Caroline Colombo; Antonella Rella; Tyler Normile; Luna S Joffe; Patricia M Tavares; Glauber R de S Araújo; Susana Frases; Erika P Orner; Amir M Farnoud; Bettina C Fries; Brian Sheridan; Leonardo Nimrichter; Marcio L Rodrigues; Maurizio Del Poeta
Journal:  mBio       Date:  2019-04-02       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.